相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association
Connie W. Tsao et al.
CIRCULATION (2022)
Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof-of-concept study
Maxime Meloche et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Sex-Based Difference in the Effect of Metoprolol on Heart Rate and Bradycardia in a Population-Based Setting
Linda C. Hendriksen et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites
Marc-Olivier Pilon et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
Kelly E. Caudle et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature
Andre Farkouh et al.
ADVANCES IN THERAPY (2020)
Sex differences in pharmacokinetics predict adverse drug reactions in women
Irving Zucker et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Mats Dehlin et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
The impact of socioeconomic position (SEP) on women's health over the lifetime
Adrienne O'Neil et al.
MATURITAS (2020)
Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study
Chio Yokose et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)
Sex differences in body composition and association with cardiometabolic risk
Melanie Schorr et al.
BIOLOGY OF SEX DIFFERENCES (2018)
The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine
Muh. Akbar Bahar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Age and sex in drug development and testing for adults
Cara Tannenbaum et al.
PHARMACOLOGICAL RESEARCH (2017)
Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits
Nathalie Chami et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Assessing patients' and GPs' ability to recognise overweight and obesity
Carmen Wong et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH (2016)
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Michael M. Givertz et al.
CIRCULATION (2015)
Genetic markers associated with cutaneous adverse drug reactions to allopurinol: aysystematic review
Samantha Jarjour et al.
PHARMACOGENOMICS (2015)
Validation of fatty acid intakes estimated by a food frequency questionnaire using erythrocyte fatty acid profiling in the Montreal Heart Institute Biobank
V. Turcot et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2015)
Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women
Flavia Franconi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
An Investigation of CYP2D6 Genotype and Response to Metoprolol CR/XL During Dose Titration in Patients With Heart Failure: A MERIT-HF Substudy
J. A. Batty et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics
C. M. Blake et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
A new illusion of height and width: taller people are perceived as thinner
Diane M. Beck et al.
PSYCHONOMIC BULLETIN & REVIEW (2013)
Sex Differences in Drug Disposition
Offie P. Soldin et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Clinical features of women with gout arthritis. A systematic review
K. J. M. Jansen Dirken-Heukensfeldt et al.
CLINICAL RHEUMATOLOGY (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Sex Differences in Pharmacokinetics and Pharmacodynamics
Offie P. Soldin et al.
CLINICAL PHARMACOKINETICS (2009)
Gender-Based Differences in Drug Prescription: Relation to Adverse Drug Reactions
Y. Zopf et al.
PHARMACOLOGY (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
The current state of knowledge on age, sex, and their interactions on clinical pharmacology
J. B. Schwartz
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol
Richard O. Day et al.
CLINICAL PHARMACOKINETICS (2007)
Tolerability of β-blockers metabolized via cytochrome P450 2D6 is sex-dependent
Petra A. Thuermann et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Underdiagnosis of obesity at a community health center
CA Lemay et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE (2003)
Effect of furosemide on renal excretion of oxypurinol and purine bases
T Yamamoto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity
BA Hamelin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
